Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients

3 Nov 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to RNA Interference and Gene Delivery
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17082793
DOI: 10.1038/sj.cgt.7701010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patientsPMID 17082793Read ↗

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseasesSemantic proximity Read ↗

Development of adenovirus serotype 35 as a gene transfer vectorSemantic proximity Read ↗

Recent advances in oncolytic adenovirus therapies for cancerSemantic proximity Read ↗

Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunitySemantic proximity Read ↗

A non-randomized, open-label, dose-finding, first-in-human trial of combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: transgene expression persists up to 17 months post-vector injectionSemantic proximity Read ↗

Human adenovirus type 35: nucleotide sequence and vector developmentSemantic proximity Read ↗

Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceSemantic proximity Read ↗

Oncolytic adenoviral therapy for glioblastoma multiformeSemantic proximity Read ↗

A Chimeric Oncolytic Adenovirus Carried by Macrophages for Glioma ImmunotherapySemantic proximity Read ↗

Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic AdenovirusesSemantic proximity Read ↗

Adenovirus as vehicle for anticancer genetic immunotherapySemantic proximity Read ↗

Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product DevelopmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.